Apolipoprotein B/apolipoprotein A1 ratio and mortality among incident peritoneal dialysis patients

Table 3 The associations of apo A1, apo B, and the apo B/apo A1 ratio (Tertile3 Vs Tertile1) with all-cause mortality and cardiovascular events

Variables	Apo A1		Apo B		Apo B/Apo A1 ratio^d
Variables	HR (95% CI)	P Value	HR (95% CI)	P Value	HR (95% CI)	P Value
All-cause mortality
Model 1^a	0.64 (0.39 - 1.08)	0.094	1.22 (0.78 - 1.90)	0.384	1.62 (1.15 - 2.29)	0.005
Model 2^b	0.47 (0.25 - 0.89)	0.020	0.92 (0.52 - 1.65)	0.789	1.59 (1.05 - 2.43)	0.031
Model 3^c	0.48 (0.24 - 0.94)	0.033	0.73 (0.31 - 1.72)	0.466	1.60 (1.02 - 2.49)	0.040
Cardiovascular events
Model 1^a	0.47 (0.25 - 0.90)	0.022	1.04 (0.60 - 1.80)	0.900	1.76 (1.17 - 2.63)	0.006
Model 2^b	0.39 (0.18 - 0.83)	0.015	0.80 (0.40 - 1.61)	0.535	1.72 (1.05 - 2.81)	0.030
Model 3^c	0.44 (0.19 - 1.02)	0.055	1.14 (0.42 - 3.10)	0.795	2.04 (1.21 - 3.44)	0.008

Apo A-1 apolipoprotein A-1, Apo B apolipoprotein B, HR Hazard ratios, 95% CI 95% confidence intervals
^aModel 1: unadjusted
^bModel 2: adjusted for age, sex, BMI, diabetes, CVD, SBP, eGFR, tKt/V, hemoglobin, N/L, and albumin
^cModel 3: model 2 adjusted for cholesterol, triglyceride, and lipid-lowering agents use
^dTertile 3 versus tertile 1

ISSN: 1476-511X